The substances we treat at The Grove Estate are alcohol, opioids (e.g., heroin, prescription painkillers), benzodiazepines (e.g., Xanax, Valium),and Stimulants (e.g., cocaine, meth).
Some of the co-occurring disorders that are commonly treated during the dual diagnosis program at The Grove Estate in Indiana include:
Alcohol & Depression/Anxiety
According to data from the CDC’s Behavioral Risk Factor Surveillance System (BRFSS), 50.0% of Indiana adults reported current alcohol use in 2020, slightly below the national average of 52.4%.
PTSD/Pain Management & Opioids
Opioid partial agonist prescribing has sharply increased across Indiana, with practitioner-written prescriptions rising by 138%—from 362,504 in 2017 to 862,198 in 2023. Pharmacies in the state dispensed 891,151 prescriptions in 2023, up 115.8% from 408,654 in 2017. These figures spotlight a growing reliance on medication-assisted treatment (MAT) in Indiana’s response to opioid use disorder, as documented in the Indiana State Government’s Progress Report.
Stimulants & ADHD
Stimulant misuse in Indiana spans both illegal substances—such as cocaine, crack cocaine, and methamphetamine—and prescription drugs including Adderall, Ritalin, and other amphetamine-based medications. In State Fiscal Year 2023, cocaine was involved in approximately 11% of all substance use treatment admissions across the state, cited as a primary, secondary, or tertiary substance. Of those cases, 4% listed cocaine as the primary drug of use—figures that remained unchanged from the previous year. These trends are detailed by the Indiana Division of Mental Health and Addiction.